ArticleCancers2021
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
Giulia Veltri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleCancers2021
Giulia Veltri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.